Evidence map›Paper›PMID 27601062›Full record

ArticleMedical microbiology and immunology2016

High prevalence of human papillomaviruses in Ghanaian pregnant women.

Marco H Schulze, Fabian M Völker, Raimond Lugert, Paul Cooper, Kai Hasenclever, Uwe Groß, Herbert Pfister, Steffi Silling

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Medical microbiology and immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Risk Factors for Cervical Cancer in Ghana.Cancer reports (Hoboken, N.J.) · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Characteristics and Related Factors of High-Risk Human Papillomavirus Infection in Pregnant Women.Medical science monitor : international medical journal of experimental and clinical research · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Marco H SchulzeInstitute for Medical Microbiology and Göttingen International Health Network, University Medical Centre, Kreuzbergring 57, 37075, Göttingen, Germany. schulze.marco@med.uni-goettingen.de.
Fabian M VölkerInstitute for Medical Microbiology and Göttingen International Health Network, University Medical Centre, Kreuzbergring 57, 37075, Göttingen, Germany.
Raimond LugertInstitute for Medical Microbiology and Göttingen International Health Network, University Medical Centre, Kreuzbergring 57, 37075, Göttingen, Germany.
Paul CooperSt. Martin de Porres Hospital, P. O. Box 06, Eikwe, Ghana.
Kai HasencleverInstitute of Virology and National Reference Centre for Papilloma- and Polyomaviruses, University of Cologne, Fürst-Pückler-Strasse 56, 50935, Cologne, Germany.
Uwe GroßInstitute for Medical Microbiology and Göttingen International Health Network, University Medical Centre, Kreuzbergring 57, 37075, Göttingen, Germany.
Herbert PfisterInstitute of Virology and National Reference Centre for Papilloma- and Polyomaviruses, University of Cologne, Fürst-Pückler-Strasse 56, 50935, Cologne, Germany.
Steffi SillingInstitute of Virology and National Reference Centre for Papilloma- and Polyomaviruses, University of Cologne, Fürst-Pückler-Strasse 56, 50935, Cologne, Germany.
University of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Data about the prevalence of human papillomaviruses (HPV) in African women with normal and abnormal cervical cytology are still scarce. Current HPV vaccines contain HPV types, which mainly represent the HPV epidemiology of industrial countries. As further developments of HPV vaccines are going on, it is necessary to regard regional differences in HPV type prevalence to ensure optimal protection by the vaccine. Vaginal swabs of Ghanaian pregnant women, routinely collected before delivery to rule out bacterial infections causing early onset sepsis, were screened for 12 high-risk (HR), 13 probably/possibly (pHR), and 18 low-risk (LR) HPV types. Most pregnant women come for delivery to the hospital. This was considered as appropriate possibility to have an unselected group of women. HPV DNA were detected in 55/165 women (33.3, 95 % CI 26.3-41.1 %). Thirty-four out of fifty-five (61.8, 95 % CI 47.7-74.3 %) of HPV-positive women were infected with HR and/or pHR HPV types. The five most prevalent HR or pHR HPV types were HPV-52 and HPV-67 (7 women each, 4.2, 95 % CI 1.9-8.9 %), HPV-53 (six women, 3.6, 95 % CI 1.5-8.1 %), HPV-45 (five women, 3.0, 95 % CI 1.1-7.3 %), and HPV-18 (four women, 2.4, 95 % CI 0.8-6.5 %), respectively. HPV-16 was found in two women only (1.2, 95 % CI 0.2-4.8 %). Future HPV vaccine research may devote special interest to HPV-67 and HPV-53 provided further studies confirm their high prevalence in the general population of Sub-Saharan African countries. The true carcinogenic potential of HPV-67, which is a member of species alpha9 including HPV-16, and so far categorized as pHR, should be clarified.

Indexed as

Cross-Sectional StudiesFemaleGhanaHumansMass ScreeningMolecular TypingPapillomaviridaePapillomavirus InfectionsPopulation SurveillancePregnancyPrevalenceRisk FactorsVaginal SmearsHigh-risk HPVHuman papillomavirusNonavalent HPV vaccinePregnantSub-Saharan AfricaVaginal swab

Identifiers

PMID27601062
OpenAlexW2530423293

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.